Literature DB >> 16854756

Successful treatment of relapsing polychondritis with mycophenolate mofetil.

Gary Goldenberg1, Omar P Sangueza, Joseph L Jorizzo.   

Abstract

We report a 50 year old man who presented to our clinic with a 5 year history of intermittent bilateral ear pain and underwent 2 biopsies which revealed nonspecific findings. A diagnosis of relapsing polychondritis was made based on positive serum antibodies to type II collagen and a wedge biopsy which revealed areas of cartilage necrosis and focal areas of perichondral inflammation with lymphocytes and histiocytes. He was successfully treated with a prednisone taper and mycophenolate mofetil 3 g per day (increased from the initial dose of 2 g per day). During his last clinic follow up, 17 months after beginning mycophenolate mofetil, our patient had no subjective symptoms and objectively had no inflammation or pain to palpation. He was continued on prednisone 5 mg daily and mycophenolate mofetil 3 g per day.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854756     DOI: 10.1080/09546630600791426

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

1.  [Successful therapy with etanercept in relapsing polychondritis].

Authors:  C Schräder; J Lohmann
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

2.  Occurrence of relapsing polychondritis with a rising cANCA titre in a cANCA-positive systemic and cerebral vasculitis patient.

Authors:  Georg Mattiassich; Markus Egger; Georg Semlitsch; Franz Rainer
Journal:  BMJ Case Rep       Date:  2013-02-15

Review 3.  Relapsing polychondritis: a description of a case and review article.

Authors:  Amr Edrees
Journal:  Rheumatol Int       Date:  2011-01-19       Impact factor: 2.631

4.  Sudden Respiratory Failure due to Tracheobronchomalacia by Relapsing Polychondritis, Successfully Rescued by Multiple Metallic Stenting and Tracheostomy.

Authors:  Daisuke Oryoji; Nobuyuki Ono; Daisuke Himeji; Kyoko Yoshihiro; Yasufumi Kai; Motohiro Matsuda; Hiroshi Tsukamoto; Akira Ueda
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.